Attached files
| file | filename |
|---|---|
| EX-4.2 - DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT OF 193 - Protara Therapeutics, Inc. | f10k2020ex4-2_protara.htm |
| EX-10.25 - LEASE BY AND BETWEEN 345 PAS HOLDING LLC, AND THE REGISTRANT, DATED AS OF DECEMB - Protara Therapeutics, Inc. | f10k2020ex10-25_protara.htm |
| EX-21.1 - LIST OF SUBSIDIARIES - Protara Therapeutics, Inc. | f10k2020ex21-1_protara.htm |
| EX-31.1 - CERTIFICATION - Protara Therapeutics, Inc. | f10k2020ex31-1_protara.htm |
| EX-32.1 - CERTIFICATION - Protara Therapeutics, Inc. | f10k2020ex32-1_protara.htm |
| EX-31.2 - CERTIFICATION - Protara Therapeutics, Inc. | f10k2020ex31-2_protara.htm |
| 10-K - ANNUAL REPORT - Protara Therapeutics, Inc. | f10k2020_protaratherapeutics.htm |
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in the Registration Statements of Protara Therapeutics, Inc. on Form S-3 (File No. 333-251224) and Form S-8 (File Nos. 333-237497, 333-235918, 333-229123, 333-222415 and 333-200587) of our report dated March 11, 2021, with respect to our audits of the consolidated financial statements of Protara Therapeutics, Inc. as of December 31, 2020 and 2019 and for the years ended December 31, 2020 and 2019, which report is included in this Annual Report on Form 10-K of Protara Therapeutics, Inc. for the year ended December 31, 2020.
/s/ Marcum llp
Marcum llp
New York, NY
March 11, 2021